Progesterone transdermal delivery system: optimization by the permeation enhancer monoolein (1999)
Source: Bollettino Chimico Farmaceutico. Conference titles: Congress of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Assunto: FARMACOTÉCNICA
ABNT
RIBEIRO, G et al. Progesterone transdermal delivery system: optimization by the permeation enhancer monoolein. Bollettino Chimico Farmaceutico. Milano: Societá Editoriale Farmaceutica. . Acesso em: 12 out. 2024. , 1999APA
Ribeiro, G., Bosso, L. C., Garcia, M. T., Hernandes, J. M. M., Freitas, O. de, Garcia, S. B., et al. (1999). Progesterone transdermal delivery system: optimization by the permeation enhancer monoolein. Bollettino Chimico Farmaceutico. Milano: Societá Editoriale Farmaceutica.NLM
Ribeiro G, Bosso LC, Garcia MT, Hernandes JMM, Freitas O de, Garcia SB, Collett JH, Bentley MVLB. Progesterone transdermal delivery system: optimization by the permeation enhancer monoolein. Bollettino Chimico Farmaceutico. 1999 ; 132( 2): XXVIII.[citado 2024 out. 12 ]Vancouver
Ribeiro G, Bosso LC, Garcia MT, Hernandes JMM, Freitas O de, Garcia SB, Collett JH, Bentley MVLB. Progesterone transdermal delivery system: optimization by the permeation enhancer monoolein. Bollettino Chimico Farmaceutico. 1999 ; 132( 2): XXVIII.[citado 2024 out. 12 ]